JT
NBIX icon

Jump Trading’s Neurocrine Biosciences NBIX Stock Holding History

Jump Trading’s Portfolio NBIX Stock Details NBIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		$422K Buy
3,461
+879
+34% +$97.1K 0.28% 64
2020
Q1 		$223K Buy
+2,582
New +$253K 0.17% 139
2019
Q3 		– Sell
-3,031
Closed -$256K – 343
2019
Q2 		$256K Sell
3,031
-783
-21% -$64.3K 0.01% 244
2019
Q1 		$336K Buy
+3,814
New +$319K 0.11% 209
2018
Q4 		– Sell
-1,987
Closed -$244K – 350
2018
Q3 		$244K Buy
+1,987
New +$225K 0.01% 271

Other funds holding NBIX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Jump Trading's NBIX Position: Q2 2020 in Review

Jump Trading increased its Neurocrine Biosciences (NBIX) stake by 34% in Q2 2020, buying an estimated $97.1K and bringing the position to 3,461 shares worth $422K. The position accounts for 0.28% of the portfolio, ranked #64.

Jump Trading first reported a position in NBIX in Q3 2018 and has held it in 5 quarters since. 419 funds tracked by Wall St. Rank hold NBIX as of Q2 2020.

  • Jump Trading held 3,461 shares of Neurocrine Biosciences worth $422K as of Q2 2020.
  • Jump Trading bought 879 Neurocrine Biosciences shares in Q2 2020, an estimated $97.1K.
  • Neurocrine Biosciences made up 0.28% of Jump Trading's portfolio in Q2 2020, its #64 holding.
  • Jump Trading first reported a position in Neurocrine Biosciences in Q3 2018 and has held it in 5 quarters since.
  • 419 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q2 2020.

Based on Jump Trading's 13F filing for Q2 2020, filed 3 Aug 2020.